These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30101709)

  • 21. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
    Abe K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tackling Alzheimer's Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles.
    Rampa A; Gobbi S; Belluti F; Bisi A
    Curr Med Chem; 2021; 28(12):2305-2327. PubMed ID: 32867634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New concepts in the drug therapy of Alzheimer's disease.
    Hake AM; Farlow MR
    Expert Opin Pharmacother; 2001 Dec; 2(12):1975-83. PubMed ID: 11825329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unlocking the concealed targets using system biology mapping for Alzheimer's disease.
    Joshi P; Kawade V; Dhulap S; Goel M
    Pharmacol Rep; 2019 Dec; 71(6):1104-1107. PubMed ID: 31634797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in Alzheimer's disease therapeutics.
    Rafii MS; Aisen PS
    BMC Med; 2009 Feb; 7():7. PubMed ID: 19228370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Progress in the Pharmacotherapy of Alzheimer's Disease.
    Khoury R; Patel K; Gold J; Hinds S; Grossberg GT
    Drugs Aging; 2017 Nov; 34(11):811-820. PubMed ID: 29116600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer's Disease.
    Chyr J; Gong H; Zhou X
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-onset Alzheimer's disease: a global cross-sectional analysis.
    Panegyres PK; Chen HY;
    Eur J Neurol; 2014 Sep; 21(9):1149-54, e64-5. PubMed ID: 24780092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
    Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N
    Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies.
    Christensen DD
    CNS Spectr; 2007 Feb; 12(2):113-6, 119-23. PubMed ID: 17277711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The past, present, and future of disease-modifying therapies for Alzheimer's disease.
    Suzuki K; Iwata A; Iwatsubo T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug development status for Alzheimer's disease: present scenario.
    Misra S; Medhi B
    Neurol Sci; 2013 Jun; 34(6):831-9. PubMed ID: 23392897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease.
    Kim TW
    Neurotherapeutics; 2015 Jan; 12(1):132-42. PubMed ID: 25549849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.